Genetic testing has been a rapidly growing field over the past decade, and there are many companies that give consumers empty promises of being able to identify their genetic predisposition to a variety of different ailments, as well as optimize the use of prescription drugs. One of the few that is able to deliver actionable results, thanks to its proprietary methods and experienced team of scientists is OmeCare. The company is at the forefront of this genetic revolution. The company is based out of San Diego, California, and it is able to offer on-target results for consumers who want to optimize the effectiveness of their prescribed medication.
OmeCare offers a product called OmePsychiatricMed, which is able to ascertain the effectiveness of various antidepressants. Such medications include mood stabilizers, atypical antipsychotics, SSRI and TCA type, and a variety of other medications prescribed for mental health. With the ongoing pandemic, people have become more and more susceptible to emotions that require the use of anti-anxiety medication, sleep medication, as well as anti-depressants. The test offered by OmeCare offers a precise method to identify which types of medications are optimal for an individual, as the foundation of their work lies in the individualized genetic predisposition of each individual.
OmePsychiatricMed is an integral tool in providing in-depth analysis of how our body responds to various medications, giving both the patient and doctor much-needed analytics that can sustain optimal treatment of a patient’s condition, through the use of prescription medication. OmeCare distinguishes itself from other companies as it is able to offer an actionable response to over fifty different medications, as well as showing which enzymes of an individual is compatible with the respective medication. This has the effect to minimize any potential adverse side effects, giving the individual the optimal treatment version of whatever ailment they seek to cure. The OmePsychiatricMed report gives detailed analysis of results by applying the genetic markers of an individual as identified by their blood test. Then, it provides categories based on the alignment of the medication with the genetics of the individual- categories include, “Preferential Use”, “Use as Directed”, “May Have Significant Limitations”, and “May Cause Serious Adverse Events”.
Another great product offered by OmeCare is PaidMeds, it is able to identify which pain medications are of most utility to the patient, providing analysis which are beneficial for both the doctor and patient- in terms of which paid medication is most effective in alleviating pain, as well as the inherent adverse side effects ,as determined by the individual’s genetic predisposition. The report gives actionable results based on thirteen different paid medications and their chemicals, which gives the individual knowledge about how their body metabolizes the drug. This leads to optimal results because the report identifies potential side-effects that can be life-threatening, adverse, or simply unpleasant.
OmeCare is vastly different from its competitors because of its proprietary systems that are able to precisely identify genetic markers, and apply the effect of a substance on personalized level. Each report assigns a score based on its scientific foundation, and does so with impeccable accuracy. Both tests can be done from the comfort of an individual’s home, using a simple cheek swab saliva test. The accuracy and precision of OmeCare, as well as its proprietary technology, is what separates this genetic company from the rest.
For more info, please check out www.omecare.co